Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1191352.RAAW-FDdNaBMfZQ_KES3W2cBdWueBi446FXgR4oQ1vzsM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1191352.RAAW-FDdNaBMfZQ_KES3W2cBdWueBi446FXgR4oQ1vzsM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1191352.RAAW-FDdNaBMfZQ_KES3W2cBdWueBi446FXgR4oQ1vzsM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1191352.RAAW-FDdNaBMfZQ_KES3W2cBdWueBi446FXgR4oQ1vzsM130_provenance.
- befree-2016 importedOn "2016-02-19" NP1191352.RAAW-FDdNaBMfZQ_KES3W2cBdWueBi446FXgR4oQ1vzsM130_provenance.
- NP1191352.RAAW-FDdNaBMfZQ_KES3W2cBdWueBi446FXgR4oQ1vzsM130_assertion wasGeneratedBy ECO_0000203 NP1191352.RAAW-FDdNaBMfZQ_KES3W2cBdWueBi446FXgR4oQ1vzsM130_provenance.
- NP1191352.RAAW-FDdNaBMfZQ_KES3W2cBdWueBi446FXgR4oQ1vzsM130_assertion wasDerivedFrom befree-2016 NP1191352.RAAW-FDdNaBMfZQ_KES3W2cBdWueBi446FXgR4oQ1vzsM130_provenance.
- NP1191352.RAAW-FDdNaBMfZQ_KES3W2cBdWueBi446FXgR4oQ1vzsM130_assertion SIO_000772 24922191 NP1191352.RAAW-FDdNaBMfZQ_KES3W2cBdWueBi446FXgR4oQ1vzsM130_provenance.
- NP1191352.RAAW-FDdNaBMfZQ_KES3W2cBdWueBi446FXgR4oQ1vzsM130_assertion evidence source_evidence_literature NP1191352.RAAW-FDdNaBMfZQ_KES3W2cBdWueBi446FXgR4oQ1vzsM130_provenance.
- NP1191352.RAAW-FDdNaBMfZQ_KES3W2cBdWueBi446FXgR4oQ1vzsM130_assertion description "[BRAF inhibitors (BRAFi) and MEK inhibitors (MEKi) increase survival in BRAF mutant metastatic melanoma patients; however, they induce a well-known spectrum of cutaneous side effects during treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1191352.RAAW-FDdNaBMfZQ_KES3W2cBdWueBi446FXgR4oQ1vzsM130_provenance.